Related Articles
Feasibility of intra-arterial chemotherapy followed by chemoembolization, every 28 days, in unresectable hepatocellular carcinoma
Cisplatin, etoposide and bleomycin infusion (PEBi regimen) in good-risk patients with germ cell tumors
Weekly carboplatin in elderly patients with advanced ovarian cancer
Carboplatin-etoposide combination chemotherapy in metastatic castration-resistant prostate cancer: A retrospective study
Toxicity profile and clinical outcomes in locally advanced head and neck cancer patients treated with induction chemotherapy prior to concurrent chemoradiation